review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Menno de Winther | Q59688356 |
K Prange | Q85197904 | ||
Tatyana Kuznetsova | Q90442060 | ||
P2093 | author name string | Christopher K Glass | |
P2860 | cites work | Monocytes in atherosclerosis: subsets and functions | Q22251045 |
Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities | Q24617969 | ||
The response-to-retention hypothesis of early atherogenesis | Q24629974 | ||
Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma | Q24685818 | ||
Molecular control of activation and priming in macrophages | Q26774972 | ||
Interferon-regulatory factors determine macrophage phenotype polarization | Q27012493 | ||
Chromatin modifications and their function | Q27861067 | ||
Cholesterol, inflammation and innate immunity | Q28086912 | ||
Histone variants--ancient wrap artists of the epigenome | Q28274796 | ||
IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses | Q28303437 | ||
Cooperative NCoR/SMRT interactions establish a corepressor-based strategy for integration of inflammatory and anti-inflammatory signaling pathways | Q28512993 | ||
Lineage-Specific Genome Architecture Links Enhancers and Non-coding Disease Variants to Target Gene Promoters | Q28592966 | ||
Antisense transcription in the mammalian transcriptome | Q29547536 | ||
Alternative activation of macrophages: mechanism and functions | Q29614350 | ||
Molecular regulation of vascular smooth muscle cell differentiation in development and disease | Q29615194 | ||
Macrophage activation and polarization | Q29616353 | ||
KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis | Q30299921 | ||
Single-Cell RNA-Seq Reveals the Transcriptional Landscape and Heterogeneity of Aortic Macrophages in Murine Atherosclerosis. | Q52653301 | ||
Mechanisms of foam cell formation in atherosclerosis. | Q52759762 | ||
The role of macrophage transcription factor MafB in atherosclerotic plaque stability. | Q53094189 | ||
CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease | Q56341189 | ||
The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection | Q57062755 | ||
The Nuclear Receptor PPARγ Controls Progressive Macrophage Polarization as a Ligand-Insensitive Epigenomic Ratchet of Transcriptional Memory | Q57457576 | ||
Transcriptome Analysis Reveals Nonfoamy Rather Than Foamy Plaque Macrophages Are Proinflammatory in Atherosclerotic Murine Models | Q57784167 | ||
Long Noncoding RNAs in Atherosclerosis: JACC Review Topic of the Week | Q58607301 | ||
Gene-specific control of inflammation by TLR-induced chromatin modifications | Q59065852 | ||
Single-cell analysis of fate-mapped macrophages reveals heterogeneity, including stem-like properties, during atherosclerosis progression and regression | Q63560426 | ||
Distribution of macrophage polarization markers in human atherosclerosis | Q63916276 | ||
Hypercholesterolemia-induced priming of hematopoietic stem and progenitor cells aggravates atherosclerosis | Q63916996 | ||
NF-κB Signaling in Macrophages: Dynamics, Crosstalk, and Signal Integration | Q64063136 | ||
CUT&Tag for efficient epigenomic profiling of small samples and single cells | Q64081920 | ||
Kallistatin Inhibits Atherosclerotic Inflammation by Regulating Macrophage Polarization | Q64376646 | ||
Granulocyte-macrophage colony-stimulating factor (GM-CSF)-induced STAT5 activation and target-gene expression during human monocyte/macrophage differentiation | Q77698627 | ||
Differentiation factors and cytokines in the atherosclerotic plaque micro-environment as a trigger for macrophage polarisation | Q84986009 | ||
Can a vascular smooth muscle-derived foam-cell really change its spots? | Q86832922 | ||
Oxidized low-density lipoprotein induces long-term proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes | Q88027071 | ||
Macrophage/microglial Ezh2 facilitates autoimmune inflammation through inhibition of Socs3 | Q88295151 | ||
Epigenetic and transcriptional regulation of IL4-induced CCL17 production in human monocytes and murine macrophages | Q89000240 | ||
Dual Roles for Ikaros in Regulation of Macrophage Chromatin State and Inflammatory Gene Expression | Q89093246 | ||
Myeloid Kdm6b deficiency results in advanced atherosclerosis | Q89123781 | ||
NF-κB signaling in inflammation | Q89348733 | ||
DNA methyltransferase 1 and Krüppel-like factor 4 axis regulates macrophage inflammation and atherosclerosis | Q91120596 | ||
SIRT1 Activation Disrupts Maintenance of Myelodysplastic Syndrome Stem and Progenitor Cells by Restoring TET2 Function | Q91146495 | ||
Tanshinone IIA harmonizes the crosstalk of autophagy and polarization in macrophages via miR-375/KLF4 pathway to attenuate atherosclerosis | Q92359574 | ||
Human monocyte-to-macrophage differentiation involves highly localized gain and loss of DNA methylation at transcription factor binding sites | Q92567993 | ||
Platelet-derived growth factor-BB-induced suppression of smooth muscle cell differentiation | Q30311540 | ||
Sp1-dependent activation of KLF4 is required for PDGF-BB-induced phenotypic modulation of smooth muscle | Q30436555 | ||
Tissue macrophages: heterogeneity and functions | Q32173810 | ||
High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3. | Q33565025 | ||
Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall | Q33567932 | ||
NCoR repression of LXRs restricts macrophage biosynthesis of insulin-sensitizing omega 3 fatty acids | Q34040157 | ||
Identification of macrophage liver X receptors as inhibitors of atherosclerosis | Q34154665 | ||
Macrophages in atherosclerosis: a dynamic balance. | Q34368005 | ||
A high-resolution map of the three-dimensional chromatin interactome in human cells | Q34378943 | ||
Histone deacetylase 9 represses cholesterol efflux and alternatively activated macrophages in atherosclerosis development | Q34440353 | ||
Environment drives selection and function of enhancers controlling tissue-specific macrophage identities | Q34452301 | ||
mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. | Q34481477 | ||
Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease. | Q34514763 | ||
Perturb-Seq: Dissecting Molecular Circuits with Scalable Single-Cell RNA Profiling of Pooled Genetic Screens | Q34547509 | ||
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice | Q34549707 | ||
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease. | Q34558126 | ||
STAT6 transcription factor is a facilitator of the nuclear receptor PPARγ-regulated gene expression in macrophages and dendritic cells | Q34641231 | ||
Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. | Q34659689 | ||
A dual cis-regulatory code links IRF8 to constitutive and inducible gene expression in macrophages | Q35104157 | ||
Cholesterol loading reprograms the microRNA-143/145-myocardin axis to convert aortic smooth muscle cells to a dysfunctional macrophage-like phenotype | Q35130704 | ||
Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. | Q35623089 | ||
Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation. | Q35624730 | ||
Transcription factors STAT6 and KLF4 implement macrophage polarization via the dual catalytic powers of MCPIP | Q35691107 | ||
A Genome-wide CRISPR Screen in Primary Immune Cells to Dissect Regulatory Networks | Q35696798 | ||
K Domain CR9 of Low Density Lipoprotein (LDL) Receptor-related Protein 1 (LRP1) Is Critical for Aggregated LDL-induced Foam Cell Formation from Human Vascular Smooth Muscle Cells | Q35721623 | ||
ATF3 protects against atherosclerosis by suppressing 25-hydroxycholesterol-induced lipid body formation | Q35894184 | ||
Nuclear receptor co-repressors are required for the histone-deacetylase activity of HDAC3 in vivo | Q36589100 | ||
Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading | Q37089500 | ||
Tissue damage drives co-localization of NF-κB, Smad3, and Nrf2 to direct Rev-erb sensitive wound repair in mouse macrophages | Q37131362 | ||
Granulocyte macrophage colony-stimulating factor induces CCL17 production via IRF4 to mediate inflammation | Q37217530 | ||
Macrophage polarization in bacterial infections | Q37259940 | ||
Endotoxin tolerance: new mechanisms, molecules and clinical significance | Q37603612 | ||
Trained immunity or tolerance: opposing functional programs induced in human monocytes after engagement of various pattern recognition receptors. | Q37712848 | ||
Protective roles of SIRT1 in atherosclerosis. | Q37835642 | ||
Epigenetic regulation of macrophage polarization and function | Q38065485 | ||
Transcriptional control of macrophage polarization | Q38103800 | ||
Macrophage phenotypes in atherosclerosis. | Q38260570 | ||
The transcriptional regulator network of human inflammatory macrophages is defined by open chromatin. | Q38299850 | ||
Function and information content of DNA methylation | Q38319920 | ||
Epigenetic pathways in macrophages emerge as novel targets in atherosclerosis | Q38500261 | ||
Macrophage activation in human diseases | Q38572817 | ||
KLF4 Regulation of Ch25h and LXR Mitigates Atherosclerosis Susceptibility | Q38631767 | ||
Opposing macrophage polarization programs show extensive epigenomic and transcriptional cross-talk | Q38712433 | ||
Pioneer transcription factors, chromatin dynamics, and cell fate control. | Q38716695 | ||
So Much Cholesterol: the unrecognized importance of smooth muscle cells in atherosclerotic foam cell formation. | Q38719850 | ||
Epigenetic Regulation of Monocyte and Macrophage Function | Q38777244 | ||
Differential gene expression in human, murine, and cell line-derived macrophages upon polarization | Q38824985 | ||
Macrophage Kdm6b controls the pro-fibrotic transcriptome signature of foam cells | Q38891314 | ||
Accumulation of serum lipids by vascular smooth muscle cells involves a macropinocytosis-like uptake pathway and is associated with the downregulation of the ATP-binding cassette transporter A1. | Q39103066 | ||
Targeting macrophage Histone deacetylase 3 stabilizes atherosclerotic lesions. | Q39162364 | ||
Methyltransferase Dnmt3a upregulates HDAC9 to deacetylate the kinase TBK1 for activation of antiviral innate immunity | Q39725913 | ||
β-Glucan Reverses the Epigenetic State of LPS-Induced Immunological Tolerance | Q40445242 | ||
New insights into the multidimensional concept of macrophage ontogeny, activation and function. | Q40866271 | ||
The transcription factor ATF7 mediates lipopolysaccharide-induced epigenetic changes in macrophages involved in innate immunological memory. | Q41024271 | ||
IFN-γ Induces Histone 3 Lysine 27 Trimethylation in a Small Subset of Promoters to Stably Silence Gene Expression in Human Macrophages. | Q41572756 | ||
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. | Q41689458 | ||
Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity. | Q41725528 | ||
IRF5:RelA interaction targets inflammatory genes in macrophages | Q41850238 | ||
DNA methylation dynamics during in vivo differentiation of blood and skin stem cells | Q41879063 | ||
Oleic acid induces smooth muscle foam cell formation and enhances atherosclerotic lesion development via CD36. | Q41975459 | ||
Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. | Q42135532 | ||
IL-4 orchestrates STAT6-mediated DNA demethylation leading to dendritic cell differentiation | Q42199311 | ||
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF. | Q42513727 | ||
Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. | Q43141233 | ||
MafB promotes atherosclerosis by inhibiting foam-cell apoptosis | Q46082307 | ||
Latent enhancers activated by stimulation in differentiated cells | Q46305342 | ||
IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans | Q46970232 | ||
BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity | Q47555324 | ||
Static and Dynamic DNA Loops form AP-1-Bound Activation Hubs during Macrophage Development | Q47692532 | ||
Type I interferons and the cytokine TNF cooperatively reprogram the macrophage epigenome to promote inflammatory activation | Q47927601 | ||
Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity. | Q49226761 | ||
Corticosterone Preexposure Increases NF-κB Translocation and Sensitizes IL-1β Responses in BV2 Microglia-Like Cells. | Q49299368 | ||
The Transcription Factor STAT6 Mediates Direct Repression of Inflammatory Enhancers and Limits Activation of Alternatively Polarized Macrophages. | Q49393104 | ||
AP-1 Transcription Factors and the BAF Complex Mediate Signal-Dependent Enhancer Selection. | Q49614247 | ||
Western Diet Triggers NLRP3-Dependent Innate Immune Reprogramming. | Q50065321 | ||
Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis. | Q50479986 | ||
The Potential Role of Trained Immunity in Autoimmune and Autoinflammatory Disorders. | Q50531937 | ||
Transdifferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis. | Q51065835 | ||
The IL-4/STAT6/PPARγ signaling axis is driving the expansion of the RXR heterodimer cistrome, providing complex ligand responsiveness in macrophages. | Q52366978 | ||
Atlas of the Immune Cell Repertoire in Mouse Atherosclerosis Defined by Single-Cell RNA-Sequencing and Mass Cytometry. | Q52653300 | ||
P433 | issue | 4 | |
P304 | page(s) | 216-228 | |
P577 | publication date | 2019-10-02 | |
P1433 | published in | Nature Reviews Cardiology | Q2108444 |
P1476 | title | Transcriptional and epigenetic regulation of macrophages in atherosclerosis | |
P478 | volume | 17 |
Q90951051 | Distinct immune microenvironments in atherosclerotic plaques |
Q89896715 | Potential Therapeutic Anti-Inflammatory and Immunomodulatory Effects of Dihydroflavones, Flavones, and Flavonols |
Q90777003 | Single-cell RNA sequencing in cardiovascular development, disease and medicine |
Q92151548 | The low-density lipoprotein cholesterol lowering is an ineffective surrogate marker of statin responsiveness to predict cardiovascular outcomes: The 10-year experience of matched population (a STROBE-compliant article) |
Search more.